Private hospitals sceptical of Mukh Mantri Sehat Yojana; fear delays, low rates; call it poll-driven by Punjab govt
Drawing from past experiences, many remain sceptical about the scheme's success, especially if the government fails to ensure timely reimbursements or make the programme financially viable.
A day after the scheme's launch, The Times of India spoke to a cross-section of private healthcare providers. Many expressed hesitation, stating they are waiting for more clarity before deciding on empanelment.
'There were two earlier schemes that had to be discontinued due to reimbursement delays and unviable rates for most procedures,' said Dr Avtar Singh of Amandeep Medicity.
He added that even the Ayushman Bharat PM-JAY Mukh Mantri Sehat Bima Yojana seems to be following a similar path.
Aam Aadmi Party National Convener Arvind Kejriwal and Punjab Chief Minister Bhagwant Mann launched the scheme in Chandigarh on Tuesday, promising that every Punjabi family would be entitled to free and cashless medical treatment up to ₹10 lakh per year at both government and private hospitals.
Citing an example, Dr Avtar said the treatment cost for a fracture was fixed at ₹9,500 — a figure that makes the procedure financially unsustainable.
He added that co-payments (the patient's share of treatment costs) were not allowed, further complicating matters.
Dr Manik Mahajan of Mahajan Hospital, Batala, said earlier government health schemes offered treatment rates too low for private hospitals to maintain quality care. He noted that in many cases, reimbursements were delayed by over a year. However, he expressed hope that the Punjab government has addressed these issues before rolling out the new scheme.
Dr Ravijit Singh of Dr Daljit Singh Eye Hospital said the success of the scheme would depend on the groundwork laid by the government and the quality of support given to both patients and private hospitals. Based on his past experience, he said insurance approvals were often denied or delayed due to inefficiencies by the Third Party Administrator (TPA) — the agency responsible for coordinating between the hospitals and government.
Several private hospital owners, speaking anonymously, said they were previously empanelled under similar schemes due to what they described as 'administrative or political pressure', which resulted in financial losses.
'In one such scheme, my hospital lost ₹6 lakh from just six patients,' one owner said, adding that at times, government hospitals referred patients to private hospitals without proper coordination or payment.
There is also growing concern among private healthcare stakeholders that the new scheme is being pushed more for political mileage ahead of the 2027 Punjab Assembly elections than for genuinely improving public healthcare in the state.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 minutes ago
- Time of India
My wife and I have Rs 8 lakh base and Rs 7 lakh top-up health insurance cover, do I need more?
Academy Empower your mind, elevate your skills It's commendable that you have maintained a claim-free health insurance record for over 15 years. It reflects well on your health and strengthens your profile with insurers. You currently have a health insurance coverage of Rs 15 lakh, including your top-up plan. At this stage, you may consider increasing your overall coverage to Rs 25-30 lakh, preferably by enhancing your top-up or opting for a super top-up with an appropriate deductible. That will ensure greater financial protection against high-value medical treatments. Additionally, it's important to review your policy for the following: l Room rent capping: If your policy limits room rent (say, 1% of sum insured), you could face out-of-pocket expenses for a higher category room. l Sub-limits on modern treatments: Check for caps or exclusions on advanced procedures like robotic surgeries, oral chemotherapy, intravitreal injections, or monoclonal antibody therapies. These treatments are becoming quite common, and sublimits can reduce the claimable amount. For instance, robotic-assisted knee replacements are now preferred for precision and recovery benefits. However, if your policy has caps on robotic surgery, you might have to bear a substantial portion of the expense yourself. So, depending on the features of your current plan, you can either continue with the same policy or explore portability within the same insurer to shift to a more comprehensive product. In any case, it is wise to proactively review and upgrade your health insurance, especially in your 60s, to stay prepared for evolving medical great that your daughter is starting health insurance at 26 with no pre-existing conditions. She will get a broad coverage at a low premium. As a baseline, we recommend she consider a sum insured of at least Rs 20-25 lakh. She should opt for a plan that includes pre- and posthospitalisation expenses, daycare procedures, and ideally OPD and mental health coverage, which is now included in most policies. It's also important to choose a plan with no disease-specific or room rent sub-limits, and to avoid co-payment clauses, wherever possible. These often reduce claim payouts and result in unexpected out-of-pocket expenses. A short waiting period for pre-existing conditions is an added bonus, even if she doesn't need it now. She should look at the insurer's claim settlement ratio and ensure a wide network of cashless hospitals for ease during emergencies. A no-claim bonus feature, which increases her coverage each year she doesn't claim, will reward her for staying healthy. A well-chosen plan now can protect her for decades and even allow seamless upgrades a question for the experts? etwealth@
Economic Times
4 minutes ago
- Economic Times
My wife and I have Rs 8 lakh base and Rs 7 lakh top-up health insurance cover, do I need more?
Getty Images Have a question for the experts? etwealth@ Our panel of experts will answer questions related to any aspect of personal finance. If you have a query, mail it to us right away. My wife (56) and I (61) are currently covered under a floater policy with Rs 8 lakh base cover and a Rs 7 lakh top-up. Do you suggest any changes in our existing coverage? Is it still possible to revise or enhance the policy at our age? We've had no claims since the policy was first taken over 15 years ago. Shilpa Arora General Manager, Co-founder and COO, Insurance Samadhan: It's commendable that you have maintained a claim-free health insurance record for over 15 years. It reflects well on your health and strengthens your profile with insurers. You currently have a health insurance coverage of Rs 15 lakh, including your top-up plan. At this stage, you may consider increasing your overall coverage to Rs 25-30 lakh, preferably by enhancing your top-up or opting for a super top-up with an appropriate deductible. That will ensure greater financial protection against high-value medical treatments. Additionally, it's important to review your policy for the following: l Room rent capping: If your policy limits room rent (say, 1% of sum insured), you could face out-of-pocket expenses for a higher category room. l Sub-limits on modern treatments: Check for caps or exclusions on advanced procedures like robotic surgeries, oral chemotherapy, intravitreal injections, or monoclonal antibody therapies. These treatments are becoming quite common, and sublimits can reduce the claimable amount. For instance, robotic-assisted knee replacements are now preferred for precision and recovery benefits. However, if your policy has caps on robotic surgery, you might have to bear a substantial portion of the expense yourself. So, depending on the features of your current plan, you can either continue with the same policy or explore portability within the same insurer to shift to a more comprehensive product. In any case, it is wise to proactively review and upgrade your health insurance, especially in your 60s, to stay prepared for evolving medical needs. My 26-year-old unmarried daughter wants to purchase medical insurance. She is healthy and has no pre-existing medical conditions. I would like you to suggest some tips so that she can choose the right policy. Sarbvir Singh Joint Group CEO, PB Fintech: It's great that your daughter is starting health insurance at 26 with no pre-existing conditions. She will get a broad coverage at a low premium. As a baseline, we recommend she consider a sum insured of at least Rs 20-25 lakh. She should opt for a plan that includes pre- and posthospitalisation expenses, daycare procedures, and ideally OPD and mental health coverage, which is now included in most policies. It's also important to choose a plan with no disease-specific or room rent sub-limits, and to avoid co-payment clauses, wherever possible. These often reduce claim payouts and result in unexpected out-of-pocket expenses. A short waiting period for pre-existing conditions is an added bonus, even if she doesn't need it now. She should look at the insurer's claim settlement ratio and ensure a wide network of cashless hospitals for ease during emergencies. A no-claim bonus feature, which increases her coverage each year she doesn't claim, will reward her for staying healthy. A well-chosen plan now can protect her for decades and even allow seamless upgrades later. Have a question for the experts? etwealth@ (Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of N.R. Narayana Murthy Founder, Infosys Watch Now Harsh Mariwala Chairman & Founder, Marico Watch Now Adar Poonawalla CEO, Serum Institute of India Watch Now Ronnie Screwvala Chairperson & Co-founder, upGrad Watch Now Puneet Dalmia Managing Director, Dalmia Bharat group Watch Now Martin Schwenk Former President & CEO, Mercedes-Benz, Thailand Watch Now Nadir Godrej Managing Director, of Godrej Industries Watch Now Manu Jain Former- Global Vice President, Xiaomi Watch Now Nithin Kamath Founder, CEO, Zerodha Watch Now Anil Agarwal Executive Chairman, Vedanta Resources Watch Now Dr. Prathap C. Reddy Founder Chairman, Apollo Hospitals Watch Now Vikram Kirloskar Former Vice Chairman, Toyota Kirloskar Motor Watch Now Kiran Mazumdar Shaw Executive Chairperson, Biocon Limited Watch Now Shashi Kiran Shetty Chairman of Allcargo Logistics, ECU Worldwide and Gati Ltd Watch Now Samir K Modi Managing Director, Modi Enterprises Watch Now R Gopalakrishnan Former Director Tata Sons, Former Vice Chairman, HUL Watch Now Sanjiv Mehta Former Chairman / CEO, Hindustan Unilever Watch Now Dr Ajai Chowdhry Co-Founder, HCL, Chairman EPIC Foundation, Author, Just Aspire Watch Now Shiv Khera Author, Business Consultant, Motivational Speaker Watch Now Nakul Anand Executive Director, ITC Limited Watch Now RS Sodhi Former MD, Amul & President, Indian Dairy Association Watch Now Anil Rai Gupta Managing Director & Chairman, Havells Watch Now Zia Mody Co-Founder & Managing Partner, AZB & Partners Watch Now Arundhati Bhattacharya Chairperson & CEO, Salesforce India Watch Now
The Print
2 hours ago
- The Print
70 pc enrolment of participants for Phase III clinical trial of dengue vaccine completed: Centre
'The trial involves over 10,000 participants, out of which more than 70 per cent enrolment has been completed. The trial has been implemented in 20 sites across India,' he said. The Indian Council of Medical Research (ICMR) has undertaken a clinical trial titled phase III, multicentre, randomised, double-blind, placebo controlled study to evaluate the efficacy, immunogenicity and safety of the single-dose Dengue Tetravalent vaccine, live attenuated (Recombinant, Lyophilised) – 'DengiAll', Jadhav said in a written reply. New Delhi, Aug 1 (PTI) Seventy per cent enrolment of participants for the Phase III clinical trial of the indigenous one-shot dengue vaccine, DengiAll, has been completed, Minister of State for Health, Prataprao Jadhav, told Lok Sabha on Friday. The sites are JSS Medical College and Hospital, Mysuru (Karnataka), Bangalore Medical College and Research Institute, and All India Institute of Medical Sciences, Bibinagar (Telangana). The approximate budget for the trial is Rs 1.3 to 1.5 crore per site, Jadhav said. According to ICMR, there is no specific antiviral treatment or licensed vaccines for dengue and the treatment is supportive in nature, Jadhav said. A total of 5,73,563 laboratory confirmed dengue cases were reported through the Integrated Health Information Platform (IHIP) in 2024, according to information shared by the National Centre for Disease Control (NCDC) , . According to ICMR, all four serotypes of the dengue virus (DENV-1, DENV-2, DENV-3, and DENV -4) are known to circulate and co-circulate in India. Multiple serotypes can be present in the same geographical region and can even infect the same individual at the same time. Hence, participants have been enrolled in the ICMR vaccine trial from different zones where these four serotypes circulate in order to test the efficacy of the vaccine against all four serotypes, Jadhav said. The minister also said that the Union Health Ministry, Director General of Health Services, and National Centre for Vector Borne Disease Control (NCVBDC) regularly monitor the situation of dengue outbreaks across the country for assessing the disease situation, preparedness, technical guidance and to sensitise and forewarn the states. Under the National Health Mission, adequate budgetary support is provided to states and Union territories for dengue control activities such as epidemic preparedness, monitoring, case management, vector control (provision of domestic breeding checkers, ASHA involvement, insecticide, fogging machines), training, intersectoral convergence, awareness activities, etc. For surveillance and free of cost diagnosis of dengue, Sentinel Surveillance Hospitals with laboratory facility and Apex Referral laboratories with advance diagnostic facilities have been identified across the country, Jadhav said. The government of India has developed national guidelines on dengue treatment/management, in consultation with experts, which have been shared with all the states and UTs for implementation. The guidelines emphasise the preparedness of hospitals for case treatment/management. In addition, advisories have been issued from time to time to states/UTs for prevention and control of dengue, including case management, the minister said. PTI PLB ARI This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
